Parkinson disease, L-dopa, and neuropathy Did we miss something?

Neurology

Volumn 77, Issue 22, 2011, Pages 1938-1939

  Tison, François ^a   Le Masson, Gwendal ^a,b  

^a HAUT LÉVÊQUE HOSPITAL   (France)

^b INSTITUT DES MALADIES NEURODÉGÉNÉRATIVES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; HOMOCYSTEINE; LEVODOPA; METHYLMALONIC ACID;

AGED; AMINO ACID BLOOD LEVEL; CROSS-SECTIONAL STUDY; CYANOCOBALAMIN DEFICIENCY; DISEASE DURATION; DRUG METABOLISM; EDITORIAL; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; NEUROPATHIC PAIN; PARKINSON DISEASE; PRIORITY JOURNAL; SENSORIMOTOR NEUROPATHY; SIDE EFFECT; VITAMIN BLOOD LEVEL;

EID: 82955225304     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31823de107     Document Type: Editorial

References (10)

1. Rajabally YA, Martey J. Neuropathy in Parkinson disease: Prevalence and determinants. Neurology 2011;77:1947- 1950.
2. Toth C, Breithaupt K, Ge S, et al. Levodopa, methylmalonic acid and neuropathy in idiopathic Parkinson's disease. Ann Neurol 2010;67:28-36.
3. Montastruc JL, Danton AC, Durrieu G, et al, French Association of Regional Pharmacovigilance Centres. Neuropathy as a potential complication of levodopa use in Parkinson's disease: A pharmacological and pharmacovigilance point of view. Mov Disord 2010;25:660-661.
4. Teodoro T, Pires D, Rosa MM, Coelho M, Sampaio C, Ferreira J. Has "levodopa-induced neuropathy" been reported in Parkinson's disease trials? Mov Disord 2011; 26:1966.
5. O'Suilleabhain P. Levodopa elevates homocysteine: Is it a problem? Arch Neurol 2004;61:633-534.
6. Muller T, Renger K, Kuhn W. Levodopa-associated increase of homocysteine levels and sural axonal degeneration. Arch Neurol 2004;61:657-660. (Pubitemid 38637680)
7. Rogers JD, Sanchez-Saffon A, Frol AB, Diaz-Arrastia R. Elevated plasma homocysteine levels in patients treated with levodopa: Association with vascular risk. Arch Neurol 2003;60:59-64. (Pubitemid 36078109)
8. Postuma RB, Espay AJ, Zadikoff C, et al. Vitamins and entacapone in levodopa-induced hyperhomocysteinemia: A randomized controlled study. Neurology 2006; 66:1941-1943. (Pubitemid 44049836)
9. Hin H, Clarke R, Sherliker P, et al. Clinical relevance of low serum vitamin B12 concentrations in older people: The Banbury B12 study. Age Ageing 2006;35:416-422. (Pubitemid 43941812)
10. Urban PP, Wellach I, Faiss S, Layer P, Rosenkranz T, Knop K, Weis J. Subacute axonal neuropathy in Parkinson's disease with cobalamin and vitamin B6 deficiency under duodopa therapy. Mov Disord 2010;25:1748-1752.